UpdatesGeneral Updates
Senores Pharmaceuticals has announced that its subsidiary, Apnar Pharma, successfully completed a USFDA inspection at its Vadodara facility with just one minor procedural observation and zero GMP issues.
Senores Pharmaceuticals LimitedSENORES · Filed with the exchange
This regulatory clearance strengthens operational reliability and export growth potential for the firm.
No comments yet. Be the first.